Doh

Abu Dhabi Global Healthcare Week Signs a Memorandum of Understanding with Digital Health New York to Advance the Digital Health Ecosystem

Retrieved on: 
Wednesday, October 4, 2023
Agreement, Partnership, Molina Healthcare, Abu Dhabi National Exhibition Centre, Department of Health (Abu Dhabi), Research, Genomics, Science, Digital health, Investment, Patient, Medicine, Artificial intelligence, Memorandum of understanding, Executive Council, Policy, Abu Dhabi National Exhibitions Company, Emirate, Doh, Abu Dhabi Executive Council, Amusement park, Pharmaceutical industry, Management

The Agreement seeks to enhance collaboration, spearhead innovation and long-term investment, and create opportunities for knowledge exchange in the global digital health ecosystem.

Key Points: 
  • The Agreement seeks to enhance collaboration, spearhead innovation and long-term investment, and create opportunities for knowledge exchange in the global digital health ecosystem.
  • Together, they will harness the innovative cultures present in New York and Abu Dhabi to inspire groundbreaking advancements in healthcare.
  • Bunny Ellerin, Co-Founder & CEO: "DHNY is thrilled to collaborate with Abu Dhabi Global Healthcare Week to unlock opportunities for knowledge exchange and promote digital health on a global scale.
  • To learn more about Abu Dhabi Global Healthcare Week, please visit: https://www.adghw.com/

Abu Dhabi Global Healthcare Week Signs a Memorandum of Understanding with Digital Health New York to Advance the Digital Health Ecosystem

Retrieved on: 
Wednesday, October 4, 2023
Agreement, Partnership, Molina Healthcare, Abu Dhabi National Exhibition Centre, Department of Health (Abu Dhabi), Research, Genomics, Science, Digital health, Investment, Patient, Medicine, Artificial intelligence, Memorandum of understanding, Executive Council, Policy, Abu Dhabi National Exhibitions Company, Emirate, Doh, Abu Dhabi Executive Council, Amusement park, Pharmaceutical industry, Management

The Agreement seeks to enhance collaboration, spearhead innovation and long-term investment, and create opportunities for knowledge exchange in the global digital health ecosystem.

Key Points: 
  • The Agreement seeks to enhance collaboration, spearhead innovation and long-term investment, and create opportunities for knowledge exchange in the global digital health ecosystem.
  • Together, they will harness the innovative cultures present in New York and Abu Dhabi to inspire groundbreaking advancements in healthcare.
  • Bunny Ellerin, Co-Founder & CEO: "DHNY is thrilled to collaborate with Abu Dhabi Global Healthcare Week to unlock opportunities for knowledge exchange and promote digital health on a global scale.
  • To learn more about Abu Dhabi Global Healthcare Week, please visit: https://www.adghw.com/

Abu Dhabi Global Healthcare Week Signs a Memorandum of Agreement with Digital Health New York to Advance the Digital Health Ecosystem

Retrieved on: 
Wednesday, October 4, 2023
Agreement, Communication, Partnership, Department of Health (Abu Dhabi), Research, Genomics, Digital health, Patient, Investment, Memorandum of understanding, Executive Council, Knowledge, Policy, Doh, Abu Dhabi Executive Council, Cryptocurrency, Pharmaceutical industry, Management

The Agreement seeks to enhance collaboration, spearhead innovation and long-term investment, and create opportunities for knowledge exchange in the global digital health ecosystem.

Key Points: 
  • The Agreement seeks to enhance collaboration, spearhead innovation and long-term investment, and create opportunities for knowledge exchange in the global digital health ecosystem.
  • Bunny Ellerin, Co-Founder & CEO: "DHNY is thrilled to collaborate with Abu Dhabi Global Healthcare Week to unlock opportunities for knowledge exchange and promote digital health on a global scale.
  • Together, they will harness the innovative cultures present in New York and Abu Dhabi to inspire groundbreaking advancements in healthcare.
  • To learn more about Abu Dhabi Global Healthcare Week, please visit: https://www.adghw.com/

Abu Dhabi Global Healthcare Week Signs a Memorandum of Agreement with Digital Health New York to Advance the Digital Health Ecosystem

Retrieved on: 
Wednesday, October 4, 2023
Agreement, Communication, Partnership, Department of Health (Abu Dhabi), Research, Multimedia, Genomics, Digital health, Patient, Investment, Memorandum of understanding, Executive Council, Knowledge, Policy, Doh, Abu Dhabi Executive Council, Cryptocurrency, Pharmaceutical industry, Management

The Agreement seeks to enhance collaboration, spearhead innovation and long-term investment, and create opportunities for knowledge exchange in the global digital health ecosystem.

Key Points: 
  • The Agreement seeks to enhance collaboration, spearhead innovation and long-term investment, and create opportunities for knowledge exchange in the global digital health ecosystem.
  • Bunny Ellerin, Co-Founder & CEO: "DHNY is thrilled to collaborate with Abu Dhabi Global Healthcare Week to unlock opportunities for knowledge exchange and promote digital health on a global scale.
  • Together, they will harness the innovative cultures present in New York and Abu Dhabi to inspire groundbreaking advancements in healthcare.
  • To learn more about Abu Dhabi Global Healthcare Week, please visit: https://www.adghw.com/
    View original content to download multimedia: https://www.prnewswire.com/news-releases/abu-dhabi-global-healthcare-wee...

Department of Health - Abu Dhabi, the UAE's healthcare regulator announces inaugural Abu Dhabi Global Healthcare Week, convening international leaders and industry experts in May 2024

Retrieved on: 
Wednesday, August 16, 2023
Heart, Partnership, Exhibition, Health, ABU, Abu Dhabi National Exhibition Centre, Department of Health (Abu Dhabi), Research, Genomics, Abu Dhabi Executive Council, Doh, Mental health, Nursing, Pharmaceutical industry, Management

"We welcome the global healthcare industry, including the most thought-provoking disruptors, influencers and strategists to join us at Abu Dhabi Global Healthcare Week in 2024 to improve global healthcare delivery, build future preparedness, and form a vision of what end-to-end healthcare will look like in a changing geopolitical, technical, and environmental landscape."

Key Points: 
  • "We welcome the global healthcare industry, including the most thought-provoking disruptors, influencers and strategists to join us at Abu Dhabi Global Healthcare Week in 2024 to improve global healthcare delivery, build future preparedness, and form a vision of what end-to-end healthcare will look like in a changing geopolitical, technical, and environmental landscape."
  • Managed by dmg events, Abu Dhabi Global Healthcare Week will elevate the narrative around future-proofing a sustainable healthcare sector locally, regionally, and globally.
  • The event will also host two awards programmes: The Philanthropy Awards and the Healthcare Innovation Awards to recognise individuals and organisations pushing the boundaries of global healthcare.
  • "Abu Dhabi is resolutely looking ahead, driven by the ambition to become a leading force in the global healthcare ecosystem.

Department of Health - Abu Dhabi, the UAE's healthcare regulator announces inaugural Abu Dhabi Global Healthcare Week, convening international leaders and industry experts in May 2024

Retrieved on: 
Wednesday, August 16, 2023
Heart, Partnership, Exhibition, Health, ABU, Abu Dhabi National Exhibition Centre, Department of Health (Abu Dhabi), Research, Multimedia, Genomics, Abu Dhabi Executive Council, Doh, Mental health, Amusement park, Nursing, Pharmaceutical industry, Management

His Excellency Mansoor Ibrahim Al Mansouri, Chairman of the Department of Health - Abu Dhabi, said: "Under the directives of our wise leadership, we continue to strengthen Abu Dhabi's position as a key player in healthcare globally.

Key Points: 
  • His Excellency Mansoor Ibrahim Al Mansouri, Chairman of the Department of Health - Abu Dhabi, said: "Under the directives of our wise leadership, we continue to strengthen Abu Dhabi's position as a key player in healthcare globally.
  • "We welcome the global healthcare industry, including the most thought-provoking disruptors, influencers and strategists to join us at Abu Dhabi Global Healthcare Week in 2024 to improve global healthcare delivery, build future preparedness, and form a vision of what end-to-end healthcare will look like in a changing geopolitical, technical, and environmental landscape."
  • Managed by dmg events, Abu Dhabi Global Healthcare Week will elevate the narrative around future-proofing a sustainable healthcare sector locally, regionally, and globally.
  • "Abu Dhabi is resolutely looking ahead, driven by the ambition to become a leading force in the global healthcare ecosystem.

Burjeel Holdings to Launch Rare Disease Research & Development Project ‘NADER’ in Partnership with US-based BridgeBio Pharma

Retrieved on: 
Wednesday, July 12, 2023
FGFR, Canavan disease, Partnership, PALO, Pantothenate kinase-associated neurodegeneration, Clinical trial, Needs assessment, ABU, Congenital adrenal hyperplasia, Achondroplasia, Research, DSM-IV codes, Innovation Center station, Craniosynostosis, Methylmalonic acidemia, Rare, Hospital, HIV disease progression rates, New Jersey Department of Health, Patient, Risk, Propionic acidemia, Algorithm, Cancer, Genetic testing, Diagnosis, Emirate, Health, Therapy, Doh, Hypochondroplasia, Pharmaceutical industry

ABU DHABI, United Arab Emirates and PALO ALTO, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- Burjeel Holdings, one of the largest healthcare providers in the MENA region, and BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, have announced a new project to revolutionize the field of early diagnosis and treatment of rare diseases or disorders in the UAE and the region. The two entities signed a preliminary, non-binding Collaboration Agreement establishing a mutual intention to work together on project ‘NADER’ (Needs Assessment and Therapeutics Development for Rare Diseases – ‘nader’ meaning ‘rare’ in Arabic). Genetic in origin, these often life-threatening or chronically debilitating diseases affect a small percentage of the population and are present throughout the person's entire life, even if symptoms do not immediately appear. The partnership will launch operations in Abu Dhabi to conduct clinical trials and research, leveraging the Emirate’s advanced infrastructure for innovation and life science.

Key Points: 
  • The partnership will launch operations in Abu Dhabi to conduct clinical trials and research, leveraging the Emirate’s advanced infrastructure for innovation and life science.
  • Project ‘NADER’ aims to revolutionize the field of early diagnosis and treatment in order to potentially improve patient outcomes.
  • Dr. Khaled Musallam, Group Chief Research Officer of Burjeel Holdings and project lead said, “Many rare diseases are highly clustered in our region due to our unique genetic pool.
  • As the collaboration unfolds, both Burjeel Holdings and BridgeBio anticipate significant progress in the field of rare diseases in the region.

Department of Health - Abu Dhabi, M42 and AbbVie enter a strategic partnership to advance personalised medicine and genomics

Retrieved on: 
Monday, June 19, 2023
BIO, Levant, Partnership, Senior, Multiple myeloma, Policy, The Department, Quality of life, ABU, Medicine, M42, Genomics, Research, Lung cancer, Translation, Pharmacotherapy, Innovation Center station, Department of Health (Abu Dhabi), AbbVie, Guideline, Memorandum of understanding, Diagnosis, Emirate, Doh, United Arab Emirates, Pharmaceutical industry

M42 is a first-of-its-kind, tech-enabled, integrated healthcare company created through the coming together of G42 Healthcare and Mubadala Health.

Key Points: 
  • M42 is a first-of-its-kind, tech-enabled, integrated healthcare company created through the coming together of G42 Healthcare and Mubadala Health.
  • The three parties aim to advance precision medicine in the diagnosis and treatment of multiple myeloma and non-small cell lung cancer.
  • As part of its preventive healthcare efforts, Abu Dhabi launched the region's first Personalised Precision Medicine Programme for oncology in 2022.
  • The programme integrates predictive, personalised and precision medicine using genomics to transform diagnostics, drug therapy and prevention and tailor it to the needs specific to individuals.

Department of Health - Abu Dhabi, M42 and AbbVie enter a strategic partnership to advance personalised medicine and genomics

Retrieved on: 
Monday, June 19, 2023
BIO, Levant, Partnership, Senior, Multiple myeloma, Policy, The Department, Quality of life, ABU, Medicine, M42, Genomics, Research, Lung cancer, Translation, Pharmacotherapy, Innovation Center station, Department of Health (Abu Dhabi), AbbVie, Guideline, Memorandum of understanding, Diagnosis, Emirate, Doh, United Arab Emirates, Pharmaceutical industry

M42 is a first-of-its-kind, tech-enabled, integrated healthcare company created through the coming together of G42 Healthcare and Mubadala Health.

Key Points: 
  • M42 is a first-of-its-kind, tech-enabled, integrated healthcare company created through the coming together of G42 Healthcare and Mubadala Health.
  • The three parties aim to advance precision medicine in the diagnosis and treatment of multiple myeloma and non-small cell lung cancer.
  • As part of its preventive healthcare efforts, Abu Dhabi launched the region's first Personalised Precision Medicine Programme for oncology in 2022.
  • The programme integrates predictive, personalised and precision medicine using genomics to transform diagnostics, drug therapy and prevention and tailor it to the needs specific to individuals.

The Department of Health - Abu Dhabi, Mass General Brigham, and International Center for Genetic Disease sign Declaration of Collaboration to Advance Life Sciences Research

Retrieved on: 
Thursday, June 15, 2023
Interim, International Center, Abu Dhabi Department of Education and Knowledge, Public, Scottish Aquaculture Innovation Centre, ABU, Massachusetts General Hospital, Genomics, United Arab Emirates, Capacity building, Department of Health (Abu Dhabi), DSM-IV codes, Patient, Mass, Mass General Brigham, Emirate, Rare, Doh, Neurology, Technology transfer, Medical device, Research

ABU DHABI, UAE, June 15, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).

Key Points: 
  • ABU DHABI, UAE, June 15, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).
  • The agreement signed is intended to advance life sciences across three strategic pillars including clinical and translational research, capacity building and technology transfer and commercialisation.
  • The collaboration aims to enhance access to innovative solutions and treatments for patients in the United Arab Emirates (UAE) and beyond.
  • Through our research collaboration with the Abu Dhabi Department of Health we intend to leverage our collective knowledge, experience, and expertise to further advance biomedical science and enhance public health.